Evidence map›Paper›PMID 33727568›Full record

ArticleScientific reports2021

PHACTR1 genetic variability is not critical in small vessel ischemic disease patients and PcomA recruitment in C57BL/6J mice.

Clemens Messerschmidt, Marco Foddis, Sonja Blumenau, Susanne Müller, Kajetan Bentele, Manuel Holtgrewe, Celia Kun-Rodrigues, Isabel Alonso, Maria do Carmo Macario, Ana Sofia Morgadinho and 24 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Genetic determinants of insufficiency of the collateral circulation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  3. A brief overview of a mouse model of cerebral hypoperfusion by bilateral carotid artery stenosis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 15 institutions in 7 countries.

Clemens MesserschmidtBerlin Institute of Health, BIH, Core Unit Bioinformatics and Charité-Universitätsmedizin Berlin, Berlin, Germany.
Marco FoddisDepartment of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Sonja BlumenauDepartment of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Susanne MüllerDepartment of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Kajetan BenteleBerlin Institute of Health, BIH, Core Unit Bioinformatics and Charité-Universitätsmedizin Berlin, Berlin, Germany.
Manuel HoltgreweBerlin Institute of Health, BIH, Core Unit Bioinformatics and Charité-Universitätsmedizin Berlin, Berlin, Germany.
Celia Kun-RodriguesCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA.
Isabel AlonsoCGPP and UnIGENe, Instituto Biologia Molecular Celular, Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
Maria do Carmo MacarioDepartment of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Ana Sofia MorgadinhoDepartment of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Ana Graça VelonDepartment of Neurology, Centro Hospitalar Trás-os-Montes e Alto Douro, Vila Real, Portugal.
Gustavo SantoDepartment of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Isabel SantanaDepartment of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Saana MönkäreDepartment of Medical Genetics, University of Helsinki, Helsinki, Finland.
Liina KuuluvainenDepartment of Medical Genetics, University of Helsinki, Helsinki, Finland.
Johanna SchleutkerLaboratory Division, Genomics, Department of Medical Genetics, Turku University Hospital, Turku, Finland.
Minna PöyhönenDepartment of Medical Genetics, University of Helsinki, Helsinki, Finland.
Liisa MyllykangasDepartment of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Assunta SenatoreInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Daniel BerchtoldDepartment of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Katarzyna WinekDepartment of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Andreas MeiselDepartment of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Aleksandra PavlovicClinic of Neurology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Vladimir KosticClinic of Neurology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Valerija DobricicClinic of Neurology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Ebba LohmannBehavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Hasmet HanagasiBehavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Gamze GuvenDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Basar BilgicBehavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Jose BrasCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA.
Rita GuerreiroCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA.
Dieter BeuleBerlin Institute of Health, BIH, Core Unit Bioinformatics and Charité-Universitätsmedizin Berlin, Berlin, Germany.
Ulrich DirnaglDepartment of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Celeste SassiDepartment of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany. celeste.sassi.10@alumni.ucl.ac.uk.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin · DEUniversity of Helsinki · FICharité - Universitätsmedizin Berlin · DEHospitais da Universidade de Coimbra · PTHumboldt-Universität zu Berlin · DEIstanbul University · TRUniversity of Belgrade · RSVan Andel Institute · USCentro Hospitalar de Trás os Montes e Alto Douro · PTFreie Universität Berlin · DEGerman Center for Neurodegenerative Diseases · DEi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTTurku University Hospital · FIUniversity of Coimbra · PTUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, several genome-wide association studies identified PHACTR1 as key locus for five diverse vascular disorders: coronary artery disease, migraine, fibromuscular dysplasia, cervical artery dissection and hypertension. Although these represent significant risk factors or comorbidities for ischemic stroke, PHACTR1 role in brain small vessel ischemic disease and ischemic stroke most important survival mechanism, such as the recruitment of brain collateral arteries like posterior communicating arteries (PcomAs), remains unknown. Therefore, we applied exome and genome sequencing in a multi-ethnic cohort of 180 early-onset independent familial and apparently sporadic brain small vessel ischemic disease and CADASIL-like Caucasian patients from US, Portugal, Finland, Serbia and Turkey and in 2 C57BL/6J stroke mouse models (bilateral common carotid artery stenosis [BCCAS] and middle cerebral artery occlusion [MCAO]), characterized by different degrees of PcomAs patency. We report 3 very rare coding variants in the small vessel ischemic disease-CADASIL-like cohort (p.Glu198Gln, p.Arg204Gly, p.Val251Leu) and a stop-gain mutation (p.Gln273*) in one MCAO mouse. These coding variants do not cluster in PHACTR1 known pathogenic domains and are not likely to play a critical role in small vessel ischemic disease or brain collateral circulation. We also exclude the possibility that copy number variants (CNVs) or a variant enrichment in Phactr1 may be associated with PcomA recruitment in BCCAS mice or linked to diverse vascular traits (cerebral blood flow pre-surgery, PcomA size, leptomeningeal microcollateral length and junction density during brain hypoperfusion) in C57BL/6J mice, respectively. Genetic variability in PHACTR1 is not likely to be a common susceptibility factor influencing small vessel ischemic disease in patients and PcomA recruitment in C57BL/6J mice. Nonetheless, rare variants in PHACTR1 RPEL domains may influence the stroke outcome and are worth investigating in a larger cohort of small vessel ischemic disease patients, different ischemic stroke subtypes and with functional studies.

Indexed as

Brain IschemiaMicrofilament ProteinsMutation, MissenseStrokeAgedAmino Acid SubstitutionAnimalsDisease Models, AnimalFemaleHumansMaleMiceMiddle AgedMicrofilament ProteinsPHACTR1 protein, humanPhactr1 protein, mouse

Identifiers

PMID33727568
PMCPMC7966789
OpenAlexW3136731920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.